Skip to main content
Erschienen in: NanoEthics 1/2016

29.02.2016 | Original Paper

“Nanostandardization” in Action: Implementing Standardization Processes in a Multidisciplinary Nanoparticle-Based Research and Development Project

verfasst von: François Roubert, Marie-Gabrielle Beuzelin-Ollivier, Margarethe Hofmann-Amtenbrink, Heinrich Hofmann, Alessandra Hool

Erschienen in: NanoEthics | Ausgabe 1/2016

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Nanomaterials have attracted much interest in the medical field and related applications as their distinct properties in the nanorange enable new and improved diagnosis and therapies. Owing to these properties and their potential interactions with the human body and the environment, the impact of nanomaterials on humans and their potential toxicity have been regarded a very significant issue. Consequently, nanomaterials are the subject of a wide range of cutting-edge research efforts in the medical and related fields to thoroughly probe their potential beneficial utilizations and their more negative effects. We posit that the lack of standardization in the field is a serious shortcoming as it has led to the establishment of methods and results that do not ensure sufficient consistency and thus in our view can possibly result in research outputs that are not as robust as they should be. The main aim of this article is to present how NanoDiaRA, a large FP7 European multidisciplinary project that seeks to investigate and develop nanotechnology-based diagnostic systems, has developed and implemented robust, standardized methods to support research practices involving the engineering and manipulation of nanomaterials. First, to contextualize this research, an overview of the measures defined by different regulatory bodies concerning nanosafety is presented. Although these authorities have been very active in the past several years, many questions remain unanswered in our view. Second, a number of national and international projects that attempted to ensure more reliable exchanges of methods and results are discussed. However, the frequent lack of publication of procedures and protocols in research can often be a hindrance for sharing those good practices. Subsequently, the efforts made through NanoDiaRA to introduce standardized methods and techniques to support the development and utilization of nanomaterials are discussed in depth. A series of semi-structured interviews were conducted with the partners of this project, and the interviews were analyzed thematically to highlight the determined efforts of the researchers to standardize their methods. Finally, some recommendations are made toward the setting up of well-defined methods to support the high-quality work of collaborative nanoparticle-based research and development projects and to enhance standardization processes.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Fußnoten
1
Partners of project DaNa are DECHEMA e.V. Frankfurt/Main, Fraunhofer Institute for Ceramic Technologies and Systems Dresden, Helmholtz Center for Environmental Research Leipzig, Karlsruhe Institute of Technology, Independent Institute for Environmental Issues Berlin (Germany), and Empa St. Gallen (Switzerland).
 
Literatur
1.
Zurück zum Zitat European Commission (2011) Commission recommendation of 18 October 2011 on the definition of nanomaterial. Off J Eur Union 275:38–40 European Commission (2011) Commission recommendation of 18 October 2011 on the definition of nanomaterial. Off J Eur Union 275:38–40
2.
Zurück zum Zitat Koodali RT, Klabunde KJ (2012) Nanotechnology: fundamental principles and applications. In: Kent JA (ed) Handbook of industrial chemistry and biotechnology, vol 1. Springer, New York Koodali RT, Klabunde KJ (2012) Nanotechnology: fundamental principles and applications. In: Kent JA (ed) Handbook of industrial chemistry and biotechnology, vol 1. Springer, New York
3.
Zurück zum Zitat Boddoes CM, Case CP, Briscoe WH (2015) Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interf Sci 218:48–68CrossRef Boddoes CM, Case CP, Briscoe WH (2015) Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interf Sci 218:48–68CrossRef
4.
Zurück zum Zitat Georgieva JV, Hoekstra D, Zuhorn IS (2014) Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood–brain barrier. Pharmaceutics 6(4):557–583CrossRef Georgieva JV, Hoekstra D, Zuhorn IS (2014) Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood–brain barrier. Pharmaceutics 6(4):557–583CrossRef
5.
Zurück zum Zitat Wang H, Thorling CA, Liang X, Bridle KR, Grice JE, Zhu Y, Crawford DHG, Xu ZP, Liu X, Roberts MS (2015) Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. J Mater Chem B 3:939–958CrossRef Wang H, Thorling CA, Liang X, Bridle KR, Grice JE, Zhu Y, Crawford DHG, Xu ZP, Liu X, Roberts MS (2015) Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. J Mater Chem B 3:939–958CrossRef
6.
Zurück zum Zitat Xu C, Sun S (2013) New forms of superparamagnetic nanoparticles for biomedical application. Adv Drug Deliv Rev 65(5):732–743CrossRef Xu C, Sun S (2013) New forms of superparamagnetic nanoparticles for biomedical application. Adv Drug Deliv Rev 65(5):732–743CrossRef
7.
Zurück zum Zitat Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27CrossRef Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27CrossRef
11.
Zurück zum Zitat Tolaymat T, El Badawy A, Sequeira R, Genaidy A (2015) An integrated science based-methodology to assess potential risks and implications of engineered nanomaterials. J Hazard Mater 298:270–281CrossRef Tolaymat T, El Badawy A, Sequeira R, Genaidy A (2015) An integrated science based-methodology to assess potential risks and implications of engineered nanomaterials. J Hazard Mater 298:270–281CrossRef
12.
Zurück zum Zitat Reinsborough MT, Sullivan G (2011) The regulation of nano-particles under the European biocidal products directive: challenges for effective civil society participation. Eur J Law Technol 2 (3) Reinsborough MT, Sullivan G (2011) The regulation of nano-particles under the European biocidal products directive: challenges for effective civil society participation. Eur J Law Technol 2 (3)
14.
Zurück zum Zitat Toy R, Peiris PM, Gaghada KB, Karathanasis E (2014) Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomed Nanotechnol Biol Med 9(1):121–134 Toy R, Peiris PM, Gaghada KB, Karathanasis E (2014) Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomed Nanotechnol Biol Med 9(1):121–134
17.
Zurück zum Zitat OECD (2009) Preliminary review of OECD test guidelines for their applicability to manufactured nanomaterials (series on the safety of manufactured nanomaterials 15). OECD, Paris OECD (2009) Preliminary review of OECD test guidelines for their applicability to manufactured nanomaterials (series on the safety of manufactured nanomaterials 15). OECD, Paris
20.
Zurück zum Zitat International Organization for Standardization (ISO) (2008) Nanotechnologies - terminology and definitions for nanoobjects - nanoparticle, nanofibre and nanoplate, ISO/TS 27687:2008. ISO, Geneva International Organization for Standardization (ISO) (2008) Nanotechnologies - terminology and definitions for nanoobjects - nanoparticle, nanofibre and nanoplate, ISO/TS 27687:2008. ISO, Geneva
21.
Zurück zum Zitat ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. S2(R1), step 4 (harmonised tripartite guideline). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Geneva ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. S2(R1), step 4 (harmonised tripartite guideline). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Geneva
22.
Zurück zum Zitat European Chemicals Agency (ECHA) (2013) Guidance on the compilation of safety data sheets, version 2.0, ECHA-13-G-11-EN. ECHA, Helsinki European Chemicals Agency (ECHA) (2013) Guidance on the compilation of safety data sheets, version 2.0, ECHA-13-G-11-EN. ECHA, Helsinki
23.
Zurück zum Zitat Bundesamt für Gesundheit (BAG) (2013) Das Sicherheitsdatenblatt in der Schweiz basierend auf der 4. BAG (Federal Office of Public Health), Bern, Revision der ChemV gültig ab 1.12.2012 Bundesamt für Gesundheit (BAG) (2013) Das Sicherheitsdatenblatt in der Schweiz basierend auf der 4. BAG (Federal Office of Public Health), Bern, Revision der ChemV gültig ab 1.12.2012
24.
Zurück zum Zitat State Secretariat for Economic Affairs (SECO) (2012) Safety data sheet (SDS): guidelines for synthetic nanomaterials. Federal Department of Economic Affairs (DEA) – SECO, Bern State Secretariat for Economic Affairs (SECO) (2012) Safety data sheet (SDS): guidelines for synthetic nanomaterials. Federal Department of Economic Affairs (DEA) – SECO, Bern
25.
Zurück zum Zitat Bleeker EAJ, Cassee FR, Geertsma RE, De Jong WH, Heugens EHW, Koers-Jacquemijns M, van De Meent D, Oomen AG, Popma J, Rietveld AG, Wijnhoven SWP (2012) Interpretation and implications of the European commission recommendation on the definition of nanomaterial (RIVM Letter Report 601358001/2012). RIVM, Bilthoven Bleeker EAJ, Cassee FR, Geertsma RE, De Jong WH, Heugens EHW, Koers-Jacquemijns M, van De Meent D, Oomen AG, Popma J, Rietveld AG, Wijnhoven SWP (2012) Interpretation and implications of the European commission recommendation on the definition of nanomaterial (RIVM Letter Report 601358001/2012). RIVM, Bilthoven
26.
Zurück zum Zitat Rauscher H (2012) The European Commission’s recommendation on the definition of nanomaterial makes an impact. Nanotoxicology 7(7):1195–1197CrossRef Rauscher H (2012) The European Commission’s recommendation on the definition of nanomaterial makes an impact. Nanotoxicology 7(7):1195–1197CrossRef
27.
Zurück zum Zitat Fulda C, Weber-Bruls D, Werth J (2014) Nano is nano is nano or: nanotechnology—a European legal perspective. Nanotechnol Rev 3(4):401–409 Fulda C, Weber-Bruls D, Werth J (2014) Nano is nano is nano or: nanotechnology—a European legal perspective. Nanotechnol Rev 3(4):401–409
28.
Zurück zum Zitat Hofmann-Amtenbrink M, Hofmann H, Hool A, Roubert F (2014) Nanotechnology in medicine: European research and its implications. Swiss Med Wkly 144:w14044. doi:10.4414/smw.2014.14044 Hofmann-Amtenbrink M, Hofmann H, Hool A, Roubert F (2014) Nanotechnology in medicine: European research and its implications. Swiss Med Wkly 144:w14044. doi:10.​4414/​smw.​2014.​14044
30.
Zurück zum Zitat Kurath M, Nentwich M, Fleischer T, Eisenberger I (2014) Cultures and strategies in the regulation of nanotechnology in Germany, Austria, Switzerland and the European Union. NanoEthics 8(2):121–140CrossRef Kurath M, Nentwich M, Fleischer T, Eisenberger I (2014) Cultures and strategies in the regulation of nanotechnology in Germany, Austria, Switzerland and the European Union. NanoEthics 8(2):121–140CrossRef
31.
Zurück zum Zitat Bergkamp L, Michaux G, Herbatschek N (2014) Nanotechnology regulation in Europe: from REACH and nano-registries to cosmetics, biocides, and medical devices. Nanotechnol Law Bus 11(1):93 Bergkamp L, Michaux G, Herbatschek N (2014) Nanotechnology regulation in Europe: from REACH and nano-registries to cosmetics, biocides, and medical devices. Nanotechnol Law Bus 11(1):93
32.
Zurück zum Zitat JRC-IHCP (2009) REACH implementation project on nanomaterials (RIP-oN) (2009) substance identification of nanomaterials, vol 1. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra JRC-IHCP (2009) REACH implementation project on nanomaterials (RIP-oN) (2009) substance identification of nanomaterials, vol 1. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra
33.
Zurück zum Zitat JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on fulfilling information requirements for nanomaterials under REACH, vol 2. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on fulfilling information requirements for nanomaterials under REACH, vol 2. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRC-IHCP), Ispra
34.
Zurück zum Zitat JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on exposure assessment and hazard/risk characterisation for nanomaterials under REACH, vol 3. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRCIHCP), Ispra JRC-IHCP (2011) REACH implementation project on nanomaterials (RIP-oN), specific advice on exposure assessment and hazard/risk characterisation for nanomaterials under REACH, vol 3. European Commission Joint Research Center - Institute for Health and Consumer Protection (JRCIHCP), Ispra
35.
Zurück zum Zitat Louekari K (2011) Integrated testing strategies in REACH. EPAA Workshop IST and their impact on the 3Rs, September 2011, Brussels Louekari K (2011) Integrated testing strategies in REACH. EPAA Workshop IST and their impact on the 3Rs, September 2011, Brussels
40.
Zurück zum Zitat Federal Office of Public Health (FOPH), Federal Office for the Environment (FOEN) (2008) Guidelines on the precautionary matrix for synthetic nanomaterials. FOPH, FOEN, Bern Federal Office of Public Health (FOPH), Federal Office for the Environment (FOEN) (2008) Guidelines on the precautionary matrix for synthetic nanomaterials. FOPH, FOEN, Bern
42.
Zurück zum Zitat EPFL (2013) Directive on the work with engineered nano materials: exposure potential and control measures. vol LEX 1.5.5 EPFL (2013) Directive on the work with engineered nano materials: exposure potential and control measures. vol LEX 1.5.5
43.
Zurück zum Zitat Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T (2010) Management of nanomaterials safety in research environment. Part Fibre Toxicol 7:40 Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T (2010) Management of nanomaterials safety in research environment. Part Fibre Toxicol 7:40
44.
45.
Zurück zum Zitat Stone V, Nowack B, Baun A, van den Brink N, Kammer F, Dusinska M, Handy R, Hankin S, Hassellov M, Joner E, Fernandes TF (2010) Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. Sci Total Environ 408(7):1745–1754. doi:10.1016/j.scitotenv.2009.10.035 CrossRef Stone V, Nowack B, Baun A, van den Brink N, Kammer F, Dusinska M, Handy R, Hankin S, Hassellov M, Joner E, Fernandes TF (2010) Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. Sci Total Environ 408(7):1745–1754. doi:10.​1016/​j.​scitotenv.​2009.​10.​035 CrossRef
47.
Zurück zum Zitat Aitken RJ, Hankin SM, Tran CL, Donaldson K, Stone V, Cumpson P, Johnstone J, Chaudhry Q, Cash S (2007) REFNANO: reference materials for engineered nanoparticle toxicology and metrology. Research Project Final Report defra Aitken RJ, Hankin SM, Tran CL, Donaldson K, Stone V, Cumpson P, Johnstone J, Chaudhry Q, Cash S (2007) REFNANO: reference materials for engineered nanoparticle toxicology and metrology. Research Project Final Report defra
51.
Zurück zum Zitat Stone V, Pozzi-Mucelli S, Tran L, Aschberger K, Sabella S, Vogel UB, Poland C, Balharry D, Fernandes S, Gottardo S, Hankin S, Hartl M, Hartmann N, Hristozov D, Hund-Rinke K, Johnston H, Marcomini A, Panzer O, Roncato D, Saber AT, Wallin H, Scott-Fordmand JJ (2014) Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part Fibre Toxicol 11:9 Stone V, Pozzi-Mucelli S, Tran L, Aschberger K, Sabella S, Vogel UB, Poland C, Balharry D, Fernandes S, Gottardo S, Hankin S, Hartl M, Hartmann N, Hristozov D, Hund-Rinke K, Johnston H, Marcomini A, Panzer O, Roncato D, Saber AT, Wallin H, Scott-Fordmand JJ (2014) Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part Fibre Toxicol 11:9
53.
Zurück zum Zitat Crist RM, Hall Grossmann J, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE (2013) Common pitfalls in nanotechnology: lessons learned from NCI’s nanotechnology characterization laboratory. Integr Biol 5:66–73CrossRef Crist RM, Hall Grossmann J, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE (2013) Common pitfalls in nanotechnology: lessons learned from NCI’s nanotechnology characterization laboratory. Integr Biol 5:66–73CrossRef
54.
Zurück zum Zitat Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ (2013) Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem Soc Rev 42(21):8339–8359. doi:10.1039/c3cs60145e CrossRef Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ (2013) Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem Soc Rev 42(21):8339–8359. doi:10.​1039/​c3cs60145e CrossRef
55.
Zurück zum Zitat Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM (2007) Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171(3):99–110. doi:10.1016/j.toxlet.2007.04.008 CrossRef Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM (2007) Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171(3):99–110. doi:10.​1016/​j.​toxlet.​2007.​04.​008 CrossRef
58.
Zurück zum Zitat International Organization for Standardization (ISO) (1992) Terms and definitions used in connection with reference materials, ISO Guide 30:1992. ISO, Geneva International Organization for Standardization (ISO) (1992) Terms and definitions used in connection with reference materials, ISO Guide 30:1992. ISO, Geneva
61.
Zurück zum Zitat Nimesh S (2011) Potential implications of nanoparticle characterization on in vitro and in vivo gene delivery. Ther Deliv 3(11):1347–1356CrossRef Nimesh S (2011) Potential implications of nanoparticle characterization on in vitro and in vivo gene delivery. Ther Deliv 3(11):1347–1356CrossRef
62.
Zurück zum Zitat Donaldson K, Murphy FA, Duffin R, Poland CA (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:5CrossRef Donaldson K, Murphy FA, Duffin R, Poland CA (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:5CrossRef
64.
Zurück zum Zitat Hofmann-Amtenbrink M (2010) NanoDiaRA internal deliverable D5.6: guidelines for improving and monitoring research exchange/ethical issues Hofmann-Amtenbrink M (2010) NanoDiaRA internal deliverable D5.6: guidelines for improving and monitoring research exchange/ethical issues
65.
Zurück zum Zitat Hool A, Beuzelin Ollivier M-G, Roubert F (2013) Managing operating procedures in distributed collaborative projects. J Phys Conf Ser 429:012071CrossRef Hool A, Beuzelin Ollivier M-G, Roubert F (2013) Managing operating procedures in distributed collaborative projects. J Phys Conf Ser 429:012071CrossRef
66.
Zurück zum Zitat Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8(1):45CrossRef Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8(1):45CrossRef
69.
Zurück zum Zitat Stefaniak AB, Hackley VA, Roebben G, Ehara K, Hankin S, Postek MT, Lynch I, Fu W-E, Linsiniger TPJ, Thünemann AF (2013) Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 7(8):1325–1337CrossRef Stefaniak AB, Hackley VA, Roebben G, Ehara K, Hankin S, Postek MT, Lynch I, Fu W-E, Linsiniger TPJ, Thünemann AF (2013) Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 7(8):1325–1337CrossRef
70.
Zurück zum Zitat Hirsch C, Roesslein M, Krug HF, Wick P (2011) Nanomaterial cell interactions: are current in vitro tests reliable? Nanomed Nanotechnol Biol Med 6(5):837–847 Hirsch C, Roesslein M, Krug HF, Wick P (2011) Nanomaterial cell interactions: are current in vitro tests reliable? Nanomed Nanotechnol Biol Med 6(5):837–847
72.
Zurück zum Zitat Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F (2015) Effects of PVA coated nanoparticles on human immune cells. Int J Nanomedicine 10:3429–3445CrossRef Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F (2015) Effects of PVA coated nanoparticles on human immune cells. Int J Nanomedicine 10:3429–3445CrossRef
Metadaten
Titel
“Nanostandardization” in Action: Implementing Standardization Processes in a Multidisciplinary Nanoparticle-Based Research and Development Project
verfasst von
François Roubert
Marie-Gabrielle Beuzelin-Ollivier
Margarethe Hofmann-Amtenbrink
Heinrich Hofmann
Alessandra Hool
Publikationsdatum
29.02.2016
Verlag
Springer Netherlands
Erschienen in
NanoEthics / Ausgabe 1/2016
Print ISSN: 1871-4757
Elektronische ISSN: 1871-4765
DOI
https://doi.org/10.1007/s11569-015-0248-8

Weitere Artikel der Ausgabe 1/2016

NanoEthics 1/2016 Zur Ausgabe